{"id":"W4390024431","doi":"10.1016/j.clgc.2023.12.010","title":"Management of Adverse Reactions Related to Lenvatinib Plus Pembrolizumab Treatment Among Patients With Renal Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Eisai Incorporated; Eisai Canada","keywords":"Medicine; Lenvatinib; Adverse effect; Pembrolizumab; Sunitinib; Internal medicine; Rash; Renal cell carcinoma; Oncology; Intensive care medicine; Cancer; Thyroid cancer; Immunotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001052783,0.0002615852,0.0005482133,0.0001568155,0.00009070197,0.000004175589,0.00009101948,0.0001098617,0.000329821],"category_scores_gemma":[0.000008743406,0.0001944925,0.0002799808,0.0005988221,0.000106536,0.00005663695,0.00009001976,0.0001588776,0.0001331604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006318794,"about_ca_system_score_gemma":0.0002093433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004818504,"about_ca_topic_score_gemma":0.00006058897,"domain_scores_codex":[0.9979145,0.00005543645,0.0007466873,0.0005623491,0.0003665031,0.0003545311],"domain_scores_gemma":[0.9985877,0.0001201624,0.0002290613,0.0005652482,0.0001454142,0.0003524755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003021745,0.002332675,0.9692373,0.0001678335,0.0007320091,0.00080575,0.0002181314,0.001171024,0.00001420336,0.00001132564,0.004206095,0.01808186],"study_design_scores_gemma":[0.0143853,0.005209838,0.9694315,0.0003292641,0.0007626358,0.000002632689,0.0001624992,0.00005458044,0.0003796652,0.00000668036,0.009086455,0.0001889481],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922971,0.0001701928,0.000001885699,0.0005002433,0.0004444005,0.001442572,0.0001071267,0.00009149942,0.004944992],"genre_scores_gemma":[0.9864796,0.001150545,0.0002698948,0.00008563057,0.0001409187,0.0007259701,0.000151171,0.00004926539,0.01094696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01789291,"threshold_uncertainty_score":0.7931175,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03796370185734156,"score_gpt":0.3437432847666835,"score_spread":0.305779582909342,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}